
Lisa Solomon
New York
Articles
-
1 month ago |
movementdisorders.onlinelibrary.wiley.com | Whitley Aamodt |David Coughlin |Lisa Solomon |Lynn Eickholt
Introduction At present, there are no disease-modifying therapies for Parkinson's disease (PD) and related disorders (PDRD) and mortality rates are rising,1 making end-of-life (EoL) care an important clinical concern. Data from general adult populations suggest that sex and racial/ethnic disparities exist at EoL.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →